(1S)-3-[(E)-2-[(1R,3aR,7aR)-1-[(2R,3E,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol

• ChemBase编号: 178041
• 分子式: C28H44O
• 平均质量: 396.64836
• 单一同位素质量: 396.33921603
• SMILES: C1(=C(C[C@H](CC1)O)/C=C/C1=CCC[C@]2([C@H]1CC[C@@H]2[C@@H](/C=C/[C@@H](C(C)C)C)C)C)C
• Canonical SMILES: O[C@H]1CCC(=C(C1)/C=C/C1=CCC[C@]2([C@H]1CC[C@@H]2[C@@H](/C=C/[C@@H](C(C)C)C)C)C)C
• InChI: InChI=1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h8-10,12-13,19-20,22,25-27,29H,7,11,14-18H2,1-6H3/b10-9+,13-12+/t20-,22+,25-,26+,27-,28+/m0/s1
• InChIKey: XQFJZHAVTPYDIQ-LETJEVNCSA-N

名称和登记号

名称

• IUPAC标准名: (1S)-3-[(E)-2-[(1R,3aR,7aR)-1-[(2R,3E,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol
• IUPAC传统名: tachysterol2
• 别名: (1S)-3-[(1E)-2-[(1R,3aR,7aR)-2,3,3a,6,7,7a-Hexahydro-7a-methyl-1-[(1R,2E,4R)-1,4,5-trimethyl-2-hexen-1-yl]-1H-inden-4-yl]ethenyl]-4-methyl-3-cyclohexen-1-ol; (3β,6E,22E)-9,10-Secoergosta-5(10),6,8,22-tetraen-3-ol; Provitamin D; Tachysterin2; Tachysterol2; Tachysterol

登记号

• CAS号: 115-61-7
• PubChem SID: 164233951
• PubChem CID: 9547230

理论计算性质

• Acid pKa: 18.314426
• 质子受体: 1
• 质子供体: 1
• LogD (pH = 5.5): 6.9926243
• LogD (pH = 7.4): 6.9926248
• Log P: 6.9926248
• 摩尔折射率: 129.9622 cm^3
• 极化性: 49.86576 Å^3
• 极化表面积: 20.23 Å^2
• 可自由旋转的化学键: 6
• 里宾斯基五规则: false

分子性质

理化性质

• 溶解度: Dichloromethane; Ethyl Acetate
• 外观: Colorless Oil

安全信息

• 保存条件: Amber Vial, -20°C Freezer, Under inert atmosphere

详细说明

Toronto Research Chemicals - T004100

Bioactive, synthetic vitamin D3 analog; exhibits antiproliferative effect on keratinocytes. Antipsoriatic.

参考文献

• Matsunaga, T., et al.: J. Dermatol., 17, 135 (1990)
• Gerritsen, M.J.P., et al.: Br. J. Dermatol., 131, 57 (1990)